KSG Investigates Bravelle the Fertility Injection by Ferring Pharmaceuticals

Kohn, Swift & Graf, P.C. is investigating claims for a class action lawsuit against Ferring Pharmaceuticals, Inc. for Bravelle©, the brand name version of urofollitropin. The drug is designed to treat infertility in women. By stimulating egg maturation and multiple follicular development, it helps women—capable of producing and releasing eggs—become pregnant; it is frequently used… Read More